ArticleMicrobes and infection2014

A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.

Chunmei Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.